The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Tonix Pharmaceuticals Closes $4.0 Million Public Offering
Jul 10, 2024•almost 2 years ago
Contract Type
contract
Chatham
Description
Tonix Pharmaceuticals Holding Corp. has announced the closing of a public offering, raising $4.0 million in gross proceeds. The company intends to utilize the net proceeds for working capital and general corporate purposes, including the preparation of a new drug application and the satisfaction of existing indebtedness.
Company Information
Company
Tonix Pharmaceuticals Holding Corp
Location
Chatham, Georgia, United States
About
Tonix is a clinical-stage biopharmaceutical company focused on developing novel therapies and vaccines to prevent and treat central nervous system disorders, immunology conditions, infectious diseases, and rare diseases.
Predictive Intelligence
Strategic
ML-powered predictions for Tonix Pharmaceuticals Holding Corp's next move
Chatham